Effect of SB203580 on Cigarette Smoke Exposure to Asthmatic Rats

LI Wen,LIN Jiang-tao,SUN Li-chao,ZHOU Tong-liang,LI Hong,PAN Lin,GUO Yan-ru,ZHANG Lan,SHU Jun
DOI: https://doi.org/10.3760/cma.j.issn.1673-436x.2012.020.001
2012-01-01
Abstract:Objective To establish model of cigarette smoke exposure to asthmatic rats and investigate the effect of a p38 mitogen-activated protein kinase(p38 MAPK) inhibitor SB203580 on the model.Methods Wistar rats were randomly divided into four groups:normal group,asthmatic group,cigarette smoke exposure to asthmatic group and SP203580 group.Rat lung function was measured by animal pulmonary function meter.ELISA was used to detect the expression of cytokines in lungs of rats.Results Compared to the cigarette smoke exposure to asthmatic group,the rats of SB203580 group had a lower airway resistance and a higher pulmonary compliance,the difference was statistically significant (P <0.05).SB203580 treatment attenuated airway inflammation.The results of ELISA showed the level of IL-4,IL-5 and IL-8 was lower in SB203580 group than cigarette smoke exposure to asthmatic group.Conclusions It is suggested that p38 MAPK inhibitor SB203580 may be effective on reducing airway inflammation and bronchial contractile response in cigarette smoke exposure to asthmatic rats.
What problem does this paper attempt to address?